公司概覽
業務類別 Biotechnology
業務概覽 Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
公司地址 825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070
電話號碼 +1 650 837-0111
傳真號碼 --
公司網頁 https://www.vaxcyte.com
員工數量 507
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Andrew L. Guggenhime, M.B.A. Chief Financial Officer and President 美元 620.00K 23/04/2026
Mr. Grant E. Pickering Director and Chief Executive Officer 美元 800.00K 23/04/2026
Mr. David R. McAvoy Chief Legal Officer, Chief Compliance Officer and Secretary -- 03/09/2026
Mr. Jim Wassil Executive Vice President and Chief Operating Officer 美元 600.00K 23/04/2026
Mr. Harp Dhaliwal Chief Technical Operations Officer 美元 495.00K 23/04/2026
Mr. Mikhail Eydelman Senior Vice President and General Counsel 美元 501.00K 03/09/2026
Ms. Elvia Cowan Senior Vice President, Finance and Principal Accounting Officer -- 24/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Carlos V. Paya,M.D.,PhD Chairman of the Board 23/04/2026
Dr. Moncef M. Slaoui, PhD Director 23/06/2026
Mr. Grant E. Pickering Director and Chief Executive Officer 23/04/2026
Dr. Olivier Raymond Brandicourt, M.D. Independent Director 23/04/2026
Ms. Halley E. Gilbert Independent Director 23/04/2026
Mr. John P. Furey Independent Director 23/04/2026
Ms. Annie Seibold Drapeau Independent Director 23/04/2026
Dr. John H. Markels, PhD Independent Director 15/07/2026
Ms. Teri Loxam, M.B.A. Independent Director 23/04/2026
 
所屬ETF (更新日期: 14/11/2026 04:20)
代號 名稱 佔比% ▼ 持有日期
MFUSPIMCO RAFI Dyn Multi-Factor US Eq ETF0.0005%30/10/2026
PWSPacer WealthShield ETF0.0004%30/10/2026
TMIDT. Rowe Price Mid-Cap Equity ResearchETF0.0004%31/10/2026
PJSMPGIM Jennison Small-Mid Cap Core Eq ETF0.0003%30/10/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0003%31/05/2023
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.0002%30/10/2026
STXGStrive 1000 Growth ETF0.0002%30/10/2026
FSEGFidelity Enhanced Small Cap Growth ETF0.0002%30/10/2026
RESMColumbia Research Enhanced Small Cap ETF0.0002%31/10/2026
TNXTT. Rowe Price Innovation Leaders ETF0.0002%31/10/2026
AVTMAvantis Total Equity Markets ETF0.0001%30/10/2026
AVIEAvantis Inflation Focused Equity ETF0.0001%30/10/2026
FFFFounders 100 ETF0.0001%30/10/2026
FSEVFidelity Enhanced Small Cap Value ETF0.0001%30/10/2026
HDGProShares Hedge Replication0.0001%30/10/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.00004%30/10/2026
RBProshares Russell 2000 Dynamic BufferETF0.00003%30/10/2026
STXVStrive 1000 Value ETF0.00002%30/10/2026
AVSUAvantis Responsible US Equity ETF0.00002%30/10/2026
AVUCAvantis U.S. Core Equity ET0.00001%30/10/2026
  1    2    3    4   5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.